These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4142788)

  • 21. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):1-16. PubMed ID: 1168624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT; Nakaw Y; Smith RT
    J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induced resistance in normal mice and growth enhancement in tumor-bearing mice by inoculation with syngeneic hybrid cells.
    Dei T; Tachibana T
    J Natl Cancer Inst; 1980 Oct; 65(4):739-49. PubMed ID: 6448309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-reacting embryonic antigen in the membrane of rat sarcoma cells which is immunogenic in the syngeneic host.
    Thomson DM; Alexander P
    Br J Cancer; 1973 Jan; 27(1):35-47. PubMed ID: 4631228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of subpopulations of immune lymphocytes against murine sarcoma cells.
    Lamon EW; Wigzell H
    Transplantation; 1974 Oct; 18(4):368-71. PubMed ID: 4547517
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. II. Blocking and unblocking of cytotoxicity.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):30-8. PubMed ID: 1168625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1978; 24(2):118-27. PubMed ID: 658547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM.
    Pollack SB; Nelson K
    Int J Cancer; 1975 Aug; 16(2):339-46. PubMed ID: 1150357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM; Botsmanov KV
    Biull Eksp Biol Med; 1974 Jul; 78(7):87-90. PubMed ID: 4451721
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor metastasis in mice with reduced immune reactivity. II. Studies with a highly antigenic MCA-induced sarcoma in thymectomized and/or sub-lethally irradiated C57BL/6J mice.
    Suurküla M; Boeryd B
    Int J Cancer; 1974 Nov; 14(5):633-41. PubMed ID: 4376529
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumour-related antigen specificities associated with 3-methylcholanthrene-treated rat embryo cells.
    Embleton MJ; Baldwin RW
    Int J Cancer; 1979 Jun; 23(6):840-5. PubMed ID: 89103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of H-2 antigens in the host response to methylcholanthrene-induced tumors.
    Ahrlund-Richter L; Klein E; Merino F
    Immunogenetics; 1982 Jan; 15(1):53-62. PubMed ID: 6979509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Properties of an SV40-transformed hamster cell line resistant to actinomycin D (author's transl)].
    Wicker BOURALI MF; Suarez HG; Cassingena R
    Int J Cancer; 1972 Nov; 10(3):632-40. PubMed ID: 4358041
    [No Abstract]   [Full Text] [Related]  

  • 34. Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.
    Hellström KE; Hellström I; Brown JP
    Int J Cancer; 1978 Mar; 21(3):317-22. PubMed ID: 75855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
    Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
    Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-bound immunity to autologous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs.
    Hellström I; Hellström KE
    Science; 1967 May; 156(3777):981-3. PubMed ID: 6023270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of tumor antigens by syngeneic antiserum on in vitro-transformed tracheal epithelial cell line 2-10-1.
    Braslawsky GR; Kennel SJ; Steele V; Nettesheim P
    Int J Cancer; 1982 Jun; 29(6):677-81. PubMed ID: 6179889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serological determination of specific surface antigens of cells from sarcomas induced by methylcholanthrene].
    Lezhneva OM
    Tsitologiia; 1970 May; 12(5):666-74. PubMed ID: 4915907
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
    Hellström KE; Hellström I
    Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.